Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis

[1]  E. Sato,et al.  Tranexamic Acid Protects Ovary and Testis Functions and Ameliorates Osteoporosis in Mice , 2020, Pharmacology.

[2]  S. Liao,et al.  Dietary lysine affects amino acid metabolism and growth performance, which may not involve the GH/IGF-1 axis, in young growing pigs. , 2020, Journal of animal science.

[3]  M. Reade,et al.  Nebulized Tranexamic Acid Therapy for Hemoptysis Associated with Submassive Pulmonary Embolism. , 2020, Journal of aerosol medicine and pulmonary drug delivery.

[4]  C. Caramella,et al.  Application of a Thermosensitive In Situ Gel of Chitosan-Based Nasal Spray Loaded with Tranexamic Acid for Localised Treatment of Nasal Wounds , 2019, AAPS PharmSciTech.

[5]  K. Hiramoto,et al.  Effect of tranexamic acid in improving the lifespan of naturally aging mice , 2019, Inflammopharmacology.

[6]  T. Bungard,et al.  Community-based management of epistaxis: Who bloody knows? , 2019, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

[7]  P. Young,et al.  In vitro characterization of physico‐chemical properties, cytotoxicity, bioactivity of urea‐crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation , 2019, International journal of pharmaceutics.

[8]  M. Burton,et al.  Tranexamic acid for patients with nasal haemorrhage (epistaxis). , 2018, The Cochrane database of systematic reviews.

[9]  P. Russo,et al.  Opportunity and challenges of nasal powders: Drug formulation and delivery , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  F. Sonvico,et al.  Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery , 2017, Drug development and industrial pharmacy.

[11]  H. Fox,et al.  Tranexamic acid in epistaxis: a systematic review , 2016, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[12]  N. Penrose,et al.  BET 1: Tranexamic acid in epistaxis: who bloody nose? , 2016, Emergency Medicine Journal.

[13]  Daniela Traini,et al.  Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  C. Merlo,et al.  Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. , 2016, JAMA.

[15]  M. Khoshayand,et al.  Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells , 2016, DARU Journal of Pharmaceutical Sciences.

[16]  G. Oliveto,et al.  Hyaluronic acid and upper airway inflammation in pediatric population: A systematic review. , 2016, International journal of pediatric otorhinolaryngology.

[17]  F. Sonvico,et al.  Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation , 2016, Drug development and industrial pharmacy.

[18]  Ignacio de Granda-Orive,et al.  CorrespondenceInhaled Tranexamic Acid as an Alternative for Hemoptysis Treatment , 2016 .

[19]  M. Nematollahi,et al.  Lysine and Leucine Deficiencies Affect Myocytes Development and IGF Signaling in Gilthead Sea Bream (Sparus aurata) , 2016, PloS one.

[20]  G. Segrelles Calvo,et al.  Inhaled Tranexamic Acid as an Alternative for Hemoptysis Treatment. , 2016, Chest.

[21]  C. Manke,et al.  Early tranexamic acid administration: A protective effect on gut barrier function following ischemia/reperfusion injury , 2015, The journal of trauma and acute care surgery.

[22]  P. Young,et al.  Inhalable tranexamic acid for haemoptysis treatment. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  C. Yuan,et al.  Tranexamic acid accelerates skin barrier recovery and upregulates occludin in damaged skin , 2014, International journal of dermatology.

[24]  Swati Pradhan-Bhatt,et al.  Hyaluronan: a simple polysaccharide with diverse biological functions. , 2014, Acta biomaterialia.

[25]  Z. Soler,et al.  Impact of synechiae after endoscopic sinus surgery on long‐term outcomes in chronic rhinosinusitis , 2013, The Laryngoscope.

[26]  I. Jaspers,et al.  Culturing of human nasal epithelial cells at the air liquid interface. , 2013, Journal of visualized experiments : JoVE.

[27]  N. Quaranta,et al.  Intranasal sodium hyaluronate on the nasal cytology of patients with allergic and nonallergic rhinitis , 2013, International forum of allergy & rhinology.

[28]  A. Ghasemi,et al.  A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial. , 2013, The American journal of emergency medicine.

[29]  I. Roberts,et al.  Tranexamic acid: less bleeding and less thrombosis? , 2012, Critical Care.

[30]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[31]  W. Jing,et al.  Effects of Dietary Lysine on Growth Performance, Serum Concentrations of Insulin-Like Growth Factor-I (IGF-I) and IGF-I mRNA Expression in Growing Rabbits , 2010 .

[32]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[33]  O. Hovorka,et al.  Expression of IGF-1R and iNOS in nasal polyps; epithelial cell homeostasis and innate immune mechanisms in pathogenesis of nasal polyposis , 2008, Folia Microbiologica.

[34]  A. Cowin,et al.  The Effect of a Hyaluronic Acid–Based Nasal Pack on Mucosal Healing in a Sheep Model of Sinusitis , 2005, American journal of rhinology.

[35]  S. Newman,et al.  Nasal distribution of budesonide inhaled via a powder inhaler. , 1993, Rhinology.